SGLT2 inhibitor therapy following aortic valve intervention for aortic stenosis: a systematic review and meta-analysis of mortality, heart failure, rhythm, renal, and valve-related outcomes.

Megantara HP, Dakota I, Taofan T, Indrian S, Aurora RG, Adiarto S

Open source

DOI
10.1186/s13019-026-04572-1
Published
2026 Jul 28
Container
Journal of cardiothoracic surgery
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13019-026-04572-1,
  title = {SGLT2 inhibitor therapy following aortic valve intervention for aortic stenosis: a systematic review and meta-analysis of mortality, heart failure, rhythm, renal, and valve-related outcomes.},
  author = {Megantara HP and Dakota I and Taofan T and Indrian S and Aurora RG and Adiarto S},
  year = {2026},
  journal = {Journal of cardiothoracic surgery},
  doi = {10.1186/s13019-026-04572-1},
  url = {https://doi.org/10.1186/s13019-026-04572-1}
}

RIS

TY  - JOUR
TI  - SGLT2 inhibitor therapy following aortic valve intervention for aortic stenosis: a systematic review and meta-analysis of mortality, heart failure, rhythm, renal, and valve-related outcomes.
AU  - Megantara HP
AU  - Dakota I
AU  - Taofan T
AU  - Indrian S
AU  - Aurora RG
AU  - Adiarto S
PY  - 2026
JO  - Journal of cardiothoracic surgery
DO  - 10.1186/s13019-026-04572-1
UR  - https://doi.org/10.1186/s13019-026-04572-1
ER  - 

APA

HP, M., I, D., T, T., S, I., RG, A., & S, A. (2026). SGLT2 inhibitor therapy following aortic valve intervention for aortic stenosis: a systematic review and meta-analysis of mortality, heart failure, rhythm, renal, and valve-related outcomes.. Journal of cardiothoracic surgery. https://doi.org/10.1186/s13019-026-04572-1

Source records